FDA — authorised 4 January 1972
- Application: NDA017010
- Marketing authorisation holder: PADAGIS US
- Local brand name: DESONIDE
- Indication: CREAM — TOPICAL
- Status: approved
🇺🇸 Verdeso in United States
FDA authorised Verdeso on 4 January 1972
Marketing authorisations
FDA — authorised 4 January 1972
- Marketing authorisation holder: PERRIGO NEW YORK
- Status: approved
FDA — authorised 26 June 1985
- Application: NDA019048
- Marketing authorisation holder: GALDERMA LABS LP
- Indication: Manufacturing (CMC)
- Status: approved
FDA — authorised 30 June 1992
- Application: ANDA073548
- Marketing authorisation holder: SUN PHARMA CANADA
- Local brand name: DESONIDE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 28 September 1992
- Application: ANDA074027
- Marketing authorisation holder: COSETTE
- Local brand name: DESONIDE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 19 May 1993
- Application: ANDA072354
- Marketing authorisation holder: GALDERMA LABS LP
- Indication: Labeling
- Status: approved
FDA — authorised 3 August 1994
- Application: ANDA074254
- Marketing authorisation holder: SUN PHARMA CANADA
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 March 2001
- Application: ANDA075751
- Marketing authorisation holder: FOUGERA PHARMS
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 19 March 2002
- Application: ANDA075860
- Marketing authorisation holder: FOUGERA PHARMS
- Local brand name: DESONIDE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 19 September 2006
- Application: NDA021978
- Marketing authorisation holder: GENUS
- Local brand name: VERDESO
- Indication: AEROSOL, FOAM — TOPICAL
- Status: approved
FDA — authorised 20 October 2006
- Application: NDA021844
- Marketing authorisation holder: LEO PHARMA AS
- Local brand name: DESONATE
- Indication: GEL — TOPICAL
- Status: approved
FDA — authorised 31 October 2014
- Application: ANDA202161
- Marketing authorisation holder: TARO
- Local brand name: DESONIDE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 27 March 2017
- Application: ANDA208836
- Marketing authorisation holder: HIKMA
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 24 July 2017
- Application: ANDA209729
- Marketing authorisation holder: GLENMARK SPECLT
- Local brand name: DESONIDE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 15 September 2017
- Application: ANDA209996
- Marketing authorisation holder: GLENMARK PHARMS LTD
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 26 September 2017
- Application: ANDA209494
- Marketing authorisation holder: GLENMARK SPECLT
- Local brand name: DESONIDE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 28 September 2017
- Application: ANDA207855
- Marketing authorisation holder: VERTICE
- Local brand name: DESONIDE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 30 January 2019
- Application: ANDA210998
- Marketing authorisation holder: ENCUBE ETHICALS
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 March 2019
- Application: ANDA212002
- Marketing authorisation holder: PAI HOLDINGS PHARM
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 23 October 2019
- Application: ANDA212473
- Marketing authorisation holder: ALEMBIC
- Local brand name: DESONIDE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 20 November 2019
- Application: ANDA210198
- Marketing authorisation holder: CADILA
- Local brand name: DESONIDE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 11 May 2020
- Application: ANDA202470
- Marketing authorisation holder: SENORES PHARMS
- Local brand name: DESONIDE
- Indication: GEL — TOPICAL
- Status: approved
FDA — authorised 24 August 2020
- Application: ANDA213632
- Marketing authorisation holder: ALEMBIC
- Local brand name: DESONIDE
- Indication: LOTION — TOPICAL
- Status: approved
FDA — authorised 8 December 2022
- Application: ANDA214396
- Marketing authorisation holder: ALEMBIC
- Local brand name: DESONIDE
- Indication: CREAM — TOPICAL
- Status: approved
Verdeso in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Verdeso approved in United States?
Yes. FDA authorised it on 4 January 1972; FDA authorised it on 4 January 1972; FDA authorised it on 26 June 1985.
Who is the marketing authorisation holder for Verdeso in United States?
PADAGIS US holds the US marketing authorisation.